Enhancer remodeling during adaptive bypass to MEK inhibition is attenuated by pharmacologic targeting of the P-TEFb complex

  • Jon S. Zawistowski
  • , Samantha M. Bevill
  • , Daniel R. Goulet
  • , Timothy J. Stuhlmiller
  • , Adriana S. Beltran
  • , Jose F. Olivares-Quintero
  • , Darshan Singh
  • , Noah Sciaky
  • , Joel S. Parker
  • , Naim U. Rashid
  • , James S. Duncan
  • , Martin C. Whittle
  • , Steven P. Angus
  • , Sara Hanna Velarde
  • , Brian T. Golitz
  • , Xiaping He
  • , Charlene Santos
  • , David B. Darr
  • , Kristalyn Gallagher
  • , Lee M. Graves
    • Charles M. Perou, Lisa A. Carey, H. Shelton Earp, Gary L. Johnson

Research output: Contribution to journal › Article › peer-review

133 Scopus citations

Fingerprint

Dive into the research topics of 'Enhancer remodeling during adaptive bypass to MEK inhibition is attenuated by pharmacologic targeting of the P-TEFb complex'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology